Items Tagged ‘infliximab’
May 6, 2016
FDA Approves of Biosimilar to Infliximab
The FDA recently approved of a biosimilar (CT-P13) to infliximab, which is used for treating IBD patients, as well as patients suffering from rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. The new drug would be the first biosimilar monoclonal antibody approved in the United States. Dr. Edward Loftus, M.D., explains how biosimilars work, and discusses […]
Tags: biosimilar, CT-P13, Edward Loftus, FDA, IBD, infliximab, rheumatoid arthritis
May 29, 2015
Infliximab Quantitation with Reflex to Antibodies to Infliximab
By Margaret Shepard, Communications Specialist 
From Mayo Medical Laboratories The new Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum, test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients. This test should be ordered to assess a trough level quantitation for evaluation of patients with loss of response to infliximab. Maria Willrich, Ph.D. gives a video overview of […]
Tags: IBD, infliximab, Mayo Medical Labs
April 30, 2015
Infliximab for Patients with Severe Ulcerative Colitis
By Margaret Shepard, Communications Specialist
Jeanne Tung, M.D., discusses infliximab for patients with severe ulcerative colitis. Specifically, Dr. Tung focuses on a recent study published in Clinical Gastroenterology and Hepatology that studied using an accelerated schedule compared to the usual dosing schedule of 6 weeks. Infliximab, otherwise known as Remicade, was approved for Crohn’s disease in 1997. Clinical trials demonstrated it […]
Tags: Clinical Gastroenterology and Hepatology, IBD, infliximab, Jeanne Tung, Remicade, ulcerative colitis
May 23, 2014
Infliximab Therapy for Pediatric IBD Patients
By Margaret Shepard, Communications Specialist
Jeanne Tung, M. D., discusses a recent article published in Inflammatory Bowel Diseases about long-term infliximab, also known as Remicade, use for pediatric inflammatory bowel disease (IBD). Remicade was approved for Crohn’s disease in 1997 and ulcerative colitis is 2005. This study is important because many parents want to know how long their child will […]
Tags: Cedars-Sinai Medical Center, IBD, Inflammatory Bowel Disease Journal, infliximab, Jeanne Tung, pediatric Crohn's disease, pediatrics, ulcerative colitis